← Back to catalogue

Procise ADL

FDA 510(k)

Class II (US FDA 510(k))

510(k) DEN220023

by ProciseDx Inc.

Identifiers

510(k) Number
DEN220023 FDA 510(k)
FDA Product Code
QYD FDA 510(k)

Classification

Device Class
Class II FDA 510(k)
Legislation / Framework
21 CFR Part 862.3115 FDA 510(k)
Regulation Number
862.3115 FDA 510(k)
Advisory Committee
Clinical Toxicology FDA 510(k)
FDA Decision
DENG FDA 510(k)

The Procise ADL is an Adalimumab Assay, a type of immunoassay for the quantitative determination of adalimumab levels in venous serum. It is designed to work with the ProciseDx Analyzer, which detects time-resolved fluorescent signal from both the donor and FRET acceptor emission within the assay. The device is classified as a Clinical Toxicology device. It is used for quantitative immunoassays, providing lab-quality results in real-time.

The Procise ADL assay is supplied for use with the ProciseDx Analyzer and is intended for the quantitative determination of adalimumab levels in patients undergoing treatment. The device has received FDA 510K authorization and is classified as a Class 2 device under the regulation number 862.3115. The assay is for single-use and is designed for use in a clinical setting, with storage and handling instructions not specified in the provided data.

Frequently asked questions

What is the Procise ADL used for?

The Procise ADL is used for the quantitative determination of adalimumab levels in patients undergoing treatment, providing lab-quality results in real-time.

Is the Procise ADL assay for single-use or reuse?

The Procise ADL assay is designed for single-use in a clinical setting.

What type of device is the Procise ADL classified as?

The Procise ADL is classified as a Clinical Toxicology device, specifically a Class 2 device under regulation number 862.3115.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: ProciseDx, PDF DEN220023 - accessdata.fda.gov, Technology — ProciseDx 2025, PROCISEDX Inc. 5430 Procise ADL - RevMed

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_510K

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
ProciseDx Inc.
FDA Applicant
Procisedx, Inc.

Sources (1)

  • FDA 510(k) DEN220023 24 fields · synced Sep 28, 2026